How Will the Market React to PerkinElmer, Inc. (PKI) Stock Getting a Bearish Rating

Monday, April 25, 2022 01:24 PM | InvestorsObserver Analysts

Mentioned in this article

How Will the Market React to PerkinElmer, Inc. (PKI) Stock Getting a Bearish Rating

The market has been down on PerkinElmer, Inc. (PKI) stock recently. PKI gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

PerkinElmer, Inc. has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on PKI!

See Full PKI Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With PKI Stock Today?

PerkinElmer, Inc. (PKI) stock is trading at $147.57 as of 1:21 PM on Monday, Apr 25, a decline of -$5.02, or -3.29% from the previous closing price of $152.59. The stock has traded between $146.12 and $150.82 so far today. Volume today is 512,308 compared to average volume of 657,202.

More About PerkinElmer, Inc.

PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software. Click Here to get the full Stock Report for PerkinElmer, Inc. stock.